Keyphrases
5-HT3 Receptor
100%
Acute Emesis
16%
All Pediatric
16%
Anticipatory Emesis
16%
Antiemetic Drugs
16%
Antiemetics
100%
Aprepitant
16%
Cannabinoids
16%
Chemotherapy
100%
Chemotherapy-induced
16%
Chemotherapy-induced Nausea
66%
Clinical Oncology
16%
Delayed Emesis
16%
Emetogenic Potential
16%
ESMO Clinical Practice Guideline
100%
European Society
16%
Granisetron
16%
Guideline Update
100%
Less Toxic
16%
MASCC
100%
Metoclopramide
16%
Multinational Association of Supportive Care in Cancer
16%
Neurokinin-1 Receptor Antagonist
16%
Ondansetron
16%
Palonosetron
16%
Pediatric Patients
16%
Phenothiazine
16%
Proposed Guidelines
16%
Updated Data
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anticipatory Nausea and Vomiting
33%
Antiemetic Agent
100%
Aprepitant
33%
Cannabinoid
33%
Chemotherapy
100%
Chemotherapy Induced Nausea and Vomiting
66%
Dexamethasone
66%
Granisetron
33%
Malignant Neoplasm
33%
Metoclopramide
33%
Palonosetron
33%
Phenothiazine
33%
Receptor Antagonist
33%
Zofran
33%